In addition, studies in lab animals pointed towards a heightened risk of a rare type of thyroid cancer, but this occurred under much higher doses and no signs of this have been observed in humans
[27] Researchers are exploring whether this effect also occurs for patients without diabetes
Cagrilintide With Retatrutide: What Is Documented, and What Is Not This is the most-searched question about the pair, so it deserves a direct answer: no clinical trial has tested cagrilintide together with retatrutide
If side effects are significant even at this dose, it may indicate the need for a slower escalation plan
Since GLP-1 medications mimic the action of a peptide produced in the GI tract, most reported mild side effects are associated with the digestive tract
Each batch is COA verified to ensure purity, consistency, and quality for controlled research environments